Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor

Cancer Research

Volumn 59, Issue 16, 1999, Pages 4129-4135

  Monsky, Wayne L ^a,b   Fukumura, Dai ^a   Gohongi, Takeshi ^a   Ancukiewcz, Marek ^a   Weich, Herbert A ^c   Torchilin, Vladimir P ^a   Yuan, Fan ^a,d   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Natl Res Center for Biotechnology   (Germany)

^d Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BASIC FIBROBLAST GROWTH FACTOR; LIPOSOME; NANOPARTICLE; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER TRANSPLANTATION; COLON CARCINOMA; GLIOMA; HUMAN; HUMAN TISSUE; MACROMOLECULE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; XENOGRAFT;

ANIMALS; BIOLOGICAL TRANSPORT; CAPILLARY PERMEABILITY; DRUG DELIVERY SYSTEMS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; LIPOSOMES; LYMPHOKINES; MACROMOLECULAR SUBSTANCES; MICE; MICROSPHERES; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033567094     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L. G., Torchilin, V. P., and Jain, R. K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA, 95: 4607-4612, 1998.
2. Gerlowski, L. E., and Jain, R. K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res., 31: 288-305, 1986.
3. Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., and Jain, R. K. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res., 54: 4564-4568, 1994.
4. Fukumura, D., Yuan, F., Monsky, W. L., Chen, Y., and Jain, R. K. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am. J. Pathol., 151: 679-688, 1997.
5. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., and Jain, R. K. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA, 93: 14765-14770, 1996.
6. Jain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., and Keshet, E. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 95: 10820-10825, 1998.
7. Jain, R. K. The Eugene M. Landis Award Lecture. Delivery of molecular and cellular medicine to solid tumors. Microcirculation, 4: 1-23, 1997.
8. Dvorak, H. F., Nagy, J. A., Dvorak, J. T., and Dvorak, A. M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol., 133: 95-109, 1988.
9. Senger, D. R., Brown, L. F., Claffey, K. P., and Dvorak, H. F. Vascular permeability factor, tumor angiogenesis, and stroma generation. Invasion Metastasis, 14: 385-394, 1994.
10. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146: 1029-1039, 1995.
11. Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. In: I. D. Goldberg and E. M. Rosen (eds.), Regulation of Angiogenesis, pp. 233-269. Basel: Birkhäuser Verlag, 1997.
12. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18: 4-25, 1997.
13. Roberts, W. G., and Palade, G. E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci., 108: 2369-2379, 1995.
14. Roberts, W. G., and Palade, G. E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res., 57: 765-772, 1997.
15. Feng, D., Nagy, J. A., Hipp, J., Dvorak, H. F., and Dvorak, A. M. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serolonin. J. Exp. Med., 183: 1981-1986, 1996.
16. Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D., and Risau, W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J. Cancer, 59: 520-529, 1994.
17. Maglione, D., Guerriero, V., Viglietto, C., Delli-Bovi, P., and Persico, M. G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA, 88: 9267-9271, 1991.
18. Hauser, S., and Weich, H. A. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors, 9: 259-268, 1993.
19. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun., 189: 824-831, 1992.
20. Samaniego, F., Markham, P. D., Gendelman, R., Watanabe, Y., Kao, V., Kowalski, K., Sonnabend, J. A., Pintus, A., Gallo, R. C., and Ensoli, B. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am. J. Pathol., 152: 1433-1443, 1998.
21. Jain, R. K., Schlenger, K., Hockel, M., and Yuan, F. Quantitative angiogenesis assays: progress and problems. Nat. Med., 3: 1203-1208, 1997.
22. Jain, R. K. The next frontier of molecular medicine: delivery of therapeutics. Nat. Med., 4: 655-657, 1998.
23. Leunig, M., Yuan, F., Menger, M. D., Boucher, Y., Goetz, A. E., Messmer, K., and Jain, R. K. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res., 52: 6553-6560, 1992.
24. Yuan, F., Leunig, M., Berk, D. A., and Jain, R. K. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc. Res., 45: 269-289, 1993.
25. Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., and Jain, R. K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res., 55: 3752-3756, 1995.
26. Fukumura, D., Salehi, H. A., Witwer, B., Tuma, R. F., Melder, R. J., and Jain, R. K. Tumor necrosis factor α-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res., 55: 4824-4829, 1995.
27. Weindel, K., Moringlane, J. R., Marme, D., and Weich, H. A. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery, 35: 439-449, 1994.
28. Dvorak, H. F., Sioussat, T. M., Brown, L. F., Berse, B., Nagy, J. A., Sotrel, A., Manseau, E. J., Van De Water, L., and Senger, D. R. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors. Concentration in tumor blood vessels. J. Exp. Med., 174: 1275-1278, 1991.
29. Hong, Q., Nagy, J. A., Senger, D. R., Dvorak, H. F., and Dvorak, A. M. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J. Histochem. Cytochem., 43: 381-389, 1995.
30. Shweiki, D., Itin, A., Neufeld, G., Gitay, G. H., and Keshet, E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest., 91: 2235-2243, 1993.
31. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 1: 1024-1028, 1995.
32. Xie, K., Huang, S., Xu, L., and Fidler, I. J. Molecular mechanisms for the regulation of vascular endothelial growth factor by extracellular and intracellular pH. Proc. Am. Assoc. Cancer Res., 39: 378, 1998.
33. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med., 3: 177-182, 1997.
34. Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., and Seed, B. Tumor induction of VEGF promoter in stromal cells. Cell, 94: 715-725, 1998.
35. Page, C. M., Rose, M., Yacoub, M., and Pigott, R. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol., 141: 673-683, 1992.
36. Thurston, G., and Baldwin, A. L. Endothelial actin cytoskeleton in rat mesentery microvasculature. Am. J. Physiol., 266: H1896-H1909, 1994.
37. Gullino, P. M., Jain, R. K., and Grantham, F. H. Temperature gradients and local perfusion in a mammary carcinoma. J. Natl. Cancer Inst., 68: 519-533, 1982.
38. Hori, K., Zhang, Q. H., Li, H. C., Saito, S., and Sato, Y. Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow. Int. J. Cancer, 65: 360-364, 1996.
39. Cheng, S-H., Nagane, M., Huang, H-J. S., and Cavenee, W. K. Intracerbral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc. Natl. Acad. Sci. USA, 94: 12081-12087, 1997.
40. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K., and Moore, M. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond.), 380: 439-442, 1996.
41. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (Lond.), 380: 435-439, 1996.
42. Tsuzuki, Y., Fukumura, D., Carmeliet, P., and Jain, R. K. Loss of HIF-1α reduces angiogenesis but not vascular permeability in ES cells derived tumors. Proc. Am. Assoc. Cancer Res., 40: 227, 1999.
43. Dvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., and Giovinco, P. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J. Immunol., 122: 166-174, 1979.
44. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harrey, V. S., and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascitic fluid. Science (Washington DC), 219: 983-985, 1983.
45. Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjoupolos, D., and Jain, R. K. Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res., 54: 3352-3356, 1994.
46. Kumar, R., Yoneda, J., and Fidler, I. J. Distinct biological activities of different angiogenic molecules. Proc. Am. Assoc. Cancer Res., 38: 53, 1997.
47. Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., and Feder, J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest., 84: 1470-1478, 1989.
48. Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N. Placenta growth factor potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem., 269: 25646-25654, 1994.
49. Murohara, T., Horovitz, J. R., Silver, M., Tsurumi, Y., Chen, D., Sullivan, A., and Isner, J. M. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 97: 99-107, 1998.
50. Jain, R. K. Delivery of molecular medicine to solid tumors. Science (Washington DC), 271: 1079-1080, 1996.